Cargando…

EGFR-mutated pulmonary adenocarcinoma with concurrent PIK3CA mutation, and with acquired RET fusion and EGFR T790M mutation after afatinib therapy

Detalles Bibliográficos
Autores principales: Kim, Minhye, Na, Ji Min, Lee, Gyeong-Won, Lee, Seung Jun, Kim, Jong Duk, Yang, Jung Wook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Pathologists and the Korean Society for Cytopathology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829570/
https://www.ncbi.nlm.nih.gov/pubmed/33260286
http://dx.doi.org/10.4132/jptm.2020.11.02
_version_ 1783641199246049280
author Kim, Minhye
Na, Ji Min
Lee, Gyeong-Won
Lee, Seung Jun
Kim, Jong Duk
Yang, Jung Wook
author_facet Kim, Minhye
Na, Ji Min
Lee, Gyeong-Won
Lee, Seung Jun
Kim, Jong Duk
Yang, Jung Wook
author_sort Kim, Minhye
collection PubMed
description
format Online
Article
Text
id pubmed-7829570
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Korean Society of Pathologists and the Korean Society for Cytopathology
record_format MEDLINE/PubMed
spelling pubmed-78295702021-02-01 EGFR-mutated pulmonary adenocarcinoma with concurrent PIK3CA mutation, and with acquired RET fusion and EGFR T790M mutation after afatinib therapy Kim, Minhye Na, Ji Min Lee, Gyeong-Won Lee, Seung Jun Kim, Jong Duk Yang, Jung Wook J Pathol Transl Med Brief Case Report The Korean Society of Pathologists and the Korean Society for Cytopathology 2021-01 2020-12-03 /pmc/articles/PMC7829570/ /pubmed/33260286 http://dx.doi.org/10.4132/jptm.2020.11.02 Text en © 2021 The Korean Society of Pathologists/The Korean Society for Cytopathology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Brief Case Report
Kim, Minhye
Na, Ji Min
Lee, Gyeong-Won
Lee, Seung Jun
Kim, Jong Duk
Yang, Jung Wook
EGFR-mutated pulmonary adenocarcinoma with concurrent PIK3CA mutation, and with acquired RET fusion and EGFR T790M mutation after afatinib therapy
title EGFR-mutated pulmonary adenocarcinoma with concurrent PIK3CA mutation, and with acquired RET fusion and EGFR T790M mutation after afatinib therapy
title_full EGFR-mutated pulmonary adenocarcinoma with concurrent PIK3CA mutation, and with acquired RET fusion and EGFR T790M mutation after afatinib therapy
title_fullStr EGFR-mutated pulmonary adenocarcinoma with concurrent PIK3CA mutation, and with acquired RET fusion and EGFR T790M mutation after afatinib therapy
title_full_unstemmed EGFR-mutated pulmonary adenocarcinoma with concurrent PIK3CA mutation, and with acquired RET fusion and EGFR T790M mutation after afatinib therapy
title_short EGFR-mutated pulmonary adenocarcinoma with concurrent PIK3CA mutation, and with acquired RET fusion and EGFR T790M mutation after afatinib therapy
title_sort egfr-mutated pulmonary adenocarcinoma with concurrent pik3ca mutation, and with acquired ret fusion and egfr t790m mutation after afatinib therapy
topic Brief Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829570/
https://www.ncbi.nlm.nih.gov/pubmed/33260286
http://dx.doi.org/10.4132/jptm.2020.11.02
work_keys_str_mv AT kimminhye egfrmutatedpulmonaryadenocarcinomawithconcurrentpik3camutationandwithacquiredretfusionandegfrt790mmutationafterafatinibtherapy
AT najimin egfrmutatedpulmonaryadenocarcinomawithconcurrentpik3camutationandwithacquiredretfusionandegfrt790mmutationafterafatinibtherapy
AT leegyeongwon egfrmutatedpulmonaryadenocarcinomawithconcurrentpik3camutationandwithacquiredretfusionandegfrt790mmutationafterafatinibtherapy
AT leeseungjun egfrmutatedpulmonaryadenocarcinomawithconcurrentpik3camutationandwithacquiredretfusionandegfrt790mmutationafterafatinibtherapy
AT kimjongduk egfrmutatedpulmonaryadenocarcinomawithconcurrentpik3camutationandwithacquiredretfusionandegfrt790mmutationafterafatinibtherapy
AT yangjungwook egfrmutatedpulmonaryadenocarcinomawithconcurrentpik3camutationandwithacquiredretfusionandegfrt790mmutationafterafatinibtherapy